These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 30196029)

  • 1. A novel nanocarrier sirolimus-coated balloon for coronary interventions: 12-Month data from the Nanoluté Registry.
    Dani S; Shah D; Sojitra P; Parikh K; Shetty R; di Palma G; Cortese B
    Cardiovasc Revasc Med; 2019 Mar; 20(3):235-240. PubMed ID: 30196029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus-coated balloon in acute and chronic coronary syndromes: the PEACE study, a subanalysis of the EASTBOURNE registry.
    Laricchia A; Bossi I; Latini RA; Lee CY; Pérez IS; Tomai F; Nuruddin AA; Buccheri D; Seresini G; Ocaranza R; Sengottvelu G; Pesenti N; Mangieri A; Cortese B;
    Rev Esp Cardiol (Engl Ed); 2024 Jul; 77(7):527-536. PubMed ID: 38056772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels.
    Sciahbasi A; Salvi N; Heang TM; Perez IS; Geraci S; Vaccaro G; Benincasa S; Nuruddin AA; Ocaranza R; Giannini F; Greco A; Cortese B
    Catheter Cardiovasc Interv; 2024 Mar; 103(4):532-538. PubMed ID: 38415895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR Inhibition by Drug-Coated Balloon: A Thor's Hammer Against Atherosclerosis?
    Cortese B; Shishehbor MH
    JACC Cardiovasc Interv; 2024 Jul; 17(13):1557-1558. PubMed ID: 38842999
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiographic performance of a novel sirolimus-coated balloon in native coronary lesions: the FAtebenefratelli SIrolimus COated NATIVES prospective registry.
    Cortese B; Pellegrini D; Latini RA; Di Palma G; Perotto A; Orrego PS
    J Cardiovasc Med (Hagerstown); 2019 Jul; 20(7):471-476. PubMed ID: 30994510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up after sirolimus-coated balloon use for coronary artery disease. Final results of the Nanolutè study.
    El-Mokdad R; di Palma G; Cortese B
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):E496-E500. PubMed ID: 32191384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison Between Sirolimus- and Paclitaxel-Coated Balloon for Revascularization of Coronary Arteries: The SIRPAC (SIRolimus-PAClitaxel) Study.
    Cortese B; Caiazzo G; Di Palma G; De Rosa S
    Cardiovasc Revasc Med; 2021 Jul; 28():1-6. PubMed ID: 33888418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Multicenter Randomized Trial to Assess the Effectiveness of the MagicTouch Sirolimus-Coated Balloon in Small Vessels: Rationale and Design of the TRANSFORM I Trial.
    Ono M; Kawashima H; Hara H; Katagiri Y; Takahashi K; Kogame N; Wykrzykowska JJ; Piek JJ; Doshi M; Sharif F; Onuma Y; Colombo A; Serruys PW; Cortese B
    Cardiovasc Revasc Med; 2021 Apr; 25():29-35. PubMed ID: 33109476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon.
    Ali RM; Abdul Kader MASK; Wan Ahmad WA; Ong TK; Liew HB; Omar AF; Mahmood Zuhdi AS; Nuruddin AA; Schnorr B; Scheller B
    JACC Cardiovasc Interv; 2019 Mar; 12(6):558-566. PubMed ID: 30898253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.
    Greco A; Sciahbasi A; Abizaid A; Mehran R; Rigattieri S; de la Torre Hernandez JM; Alfonso F; Cortese B
    Catheter Cardiovasc Interv; 2022 Oct; 100(4):544-552. PubMed ID: 36054266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group.
    Jeger RV; Eccleshall S; Wan Ahmad WA; Ge J; Poerner TC; Shin ES; Alfonso F; Latib A; Ong PJ; Rissanen TT; Saucedo J; Scheller B; Kleber FX;
    JACC Cardiovasc Interv; 2020 Jun; 13(12):1391-1402. PubMed ID: 32473887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus-Coated Balloon With a Microsphere-Based Technology for the Treatment of De Novo or Restenotic Coronary Lesions.
    Costa RA; Mandal SC; Hazra PK; Chopda M; Chandra P; Damiani LP; Abizaid A; Hiremath S
    Cardiovasc Revasc Med; 2022 Dec; 45():18-25. PubMed ID: 36192319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions.
    Scheller B; Mangner N; Abdul Kader MASK; Wan Ahmad WA; Jeger R; Wöhrle J; Ong TK; Liew HB; Gori T; Mahfoud F; Nuruddin AA; Woitek F; Abidin IZ; Schwenke C; Schnorr B; Mohd Ali R
    Circ Cardiovasc Interv; 2022 Sep; 15(9):e012305. PubMed ID: 36126132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
    Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents.
    Kufner S; Ernst M; Cassese S; Joner M; Mayer K; Colleran R; Koppara T; Xhepa E; Koch T; Wiebe J; Ibrahim T; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A; Byrne RA;
    J Am Coll Cardiol; 2020 Jul; 76(2):146-158. PubMed ID: 32646563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of long stenting in the drug-eluting stent era: patient-level pooled analysis from the GRAND-DES registry.
    Kong MG; Han JK; Kang JH; Zheng C; Yang HM; Park KW; Kang HJ; Koo BK; Chae IH; Kim HS;
    EuroIntervention; 2021 Mar; 16(16):1318-1325. PubMed ID: 31543496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study).
    Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Schunkert H; Colleran R; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA
    Eur Heart J; 2020 Oct; 41(38):3715-3728. PubMed ID: 31511862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus-coated balloon in all-comer population of coronary artery disease patients: the EASTBOURNE DIABETES prospective registry.
    Caiazzo G; Oliva A; Testa L; Heang TM; Lee CY; Milazzo D; Stefanini G; Pesenti N; Mangieri A; Colombo A; Cortese B;
    Cardiovasc Diabetol; 2024 Feb; 23(1):52. PubMed ID: 38310281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective.
    Qamar SUR; Spahić L; Benolić L; Zivanovic M; Filipović N
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514000
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.